Table 1 Association of CHD1L protein expression with clinic-pathological parameter
CHD1L protein expression | ||||
|---|---|---|---|---|
Variable | Allcase | negative | positive | P Valuea |
Age at surgery (years) | 0.168 | |||
≤ 51 b | 54 | 23(52.6%) | 31(57.4%) | |
> 51 | 48 | 27(56.2%) | 21(43.8%) | |
Histological type | ||||
Serous | 72 | 35(48.6%) | 37(51.4%) | 0.029 |
Mucinous | 11 | 9(81.8%) | 2(18.2%) | |
Othersc | 19 | 6(32.6%) | 13(68.4%) | |
Histologicalgrade(Silveberg) | 0.745 | |||
G1 | 16 | 9(56.2%) | 7(43.8%) | |
G2 | 61 | 30(48.2%) | 31(50.8%) | |
G3 | 25 | 11(44.0%) | 14(56.0%) | |
FIGO stage | 0.354 | |||
I | 19 | 8(42.1%) | 11(57.9%) | |
II | 10 | 7(70.0%) | 3(30.0%) | |
III | 58 | 26(44.8%) | 32(55.2%) | |
IV | 15 | 9(60.0%) | 6(40.0%) | |
Residual tumor | 0.469 | |||
None | 32 | 15(46.9%) | 17(53.1%) | |
<=2cm | 35 | 15(42.9%) | 20(57.1%) | |
>2cm | 35 | 20(47.1%) | 15(42.9%) | |